logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 13 of 13 Items
Showing 1 - 13 of 13 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox now

McNab C, Torreele E, Alakija A, Aluso A, Cárdenas M,  et al.
2024-10-17 • PLOS Global Public Health
2024-10-17 • PLOS Global Public Health
Journal Article
|
Letter

On the importance and challenges of global access to proven life-saving treatments for Ebolavirus – Authors' reply

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH,  et al.
2023-04-01 • Lancet Infectious Diseases
2023-04-01 • Lancet Infectious Diseases
Journal Article
|
Commentary

Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH,  et al.
2023-01-19 • Lancet Infectious Diseases
2023-01-19 • Lancet Infectious Diseases
Three years since proving effective for Ebola virus disease in a clinical trial, two breakthrough treatments are registered and stockpiled in the USA but still not registered and general...
Journal Article
|
Commentary

Reboot biomedical R&D in the global public interest

Swaminathan S, Pecoul B, Abdullah H, Christou C, Gray G,  et al.
2022-02-09 • Nature
2022-02-09 • Nature
Journal Blog
|
Perspective

The search for new antibiotics—market based solutions are not the answer

Torreele E
2019-07-11 • British Medical Journal (BMJ)
2019-07-11 • British Medical Journal (BMJ)
Journal Article
|
Editorial

Ensuring access to life-saving medicines as countries shift from Global Fund support

Tatay M, Torreele E
2019-05-01 • Bulletin of the World Health Organization
2019-05-01 • Bulletin of the World Health Organization
Journal Article
|
Short Report

An open source pharma roadmap

Balasegaram M, Kolb P, McKew J, Menon J, Olliaro PL,  et al.
2017-04-18 • PLOS Medicine
2017-04-18 • PLOS Medicine
Journal Article
|
Commentary

How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa

Boum Y II, Ouattara AK, Torreele E, Okonta C
2021-02-01 • BMJ Global Health
2021-02-01 • BMJ Global Health
SUMMARY POINTS

• Limited access to vaccines by African nations as Africa has been side-lined in the race to secure vaccines for COVID-19.
•. Uniform thinking and planning o...
Journal Article
|
Editorial

Tuberculosis and antimicrobial resistance - new models of research and development needed

Brigden G, Castro JL, Ditiu L, Gray G, Hanna D,  et al.
2017-05-01 • Bulletin of the World Health Organization
2017-05-01 • Bulletin of the World Health Organization
Journal Article
|
Research

Global Framework on Essential Health R&D

Chirac P, Torreele E
2006-05-13 • Lancet
2006-05-13 • Lancet
Journal Article
|
Letter

Neglected diseases of global importance

Ford NP, Torreele E
2001-12-19 • JAMA
2001-12-19 • JAMA
To the Editor: We agree with Mr Folkers and Dr Fauci that the success of acquired immunodeficiency syndrome research over the last 2 decades shows what can be achieved if enough financia...
Journal Article
|
Research

Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru

Guthmann JP, Arlt D, Garcia LML, Rosales M, Jesus Sanchez J,  et al.
2005-09-01 • Tropical Medicine and International Health
2005-09-01 • Tropical Medicine and International Health
Mucocutaneous leishmaniasis (MCL) is an important health problem in many rural areas of Latin America, but there are few data on the results of programmatic approaches to control the dis...
Journal Article
|
Research

Drug development for neglected diseases: a deficient market and a public-health policy failure

Trouiller P, Olliaro PL, Torreele E, Orbinski J, Laing R,  et al.
2002-06-22 • Lancet
2002-06-22 • Lancet
There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We an...